
IDEAYA BIOSCIENCES INC
IDYANASDAQ🏆 #1469 by market capEarnings Nov 3US Equity
$36.89▲ $0.05 (+0.14%)
Live1h▲ 0.2%
24h▲ 0.1%
7d▲ 2.3%
14d▲ 3.8%
30d▲ 2.0%
1y▲ 56.2%
🏦Market Cap
$3.51B
Small Cap
📈Revenue Growth (YoY)
+3118.1%
High Growth
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
15.2x
Expensive
Otter Score
65
Fair
📊
Analyst Ratings
Price
$36.89
Total
25
Raised
0
Lowered
1
Avg PT
$57.00
H / L
$63 / $48
| Institution | Action | Rating | Date |
|---|---|---|---|
Truist Securities | Reiterated | Buy | 2026-07-07 |
RBC Capital | Reiterated | Outperform | 2026-07-07 |
Wedbush | Reiterated | Outperform | 2026-06-12 |
Mizuho | Reiterated | Outperform | 2026-05-07 |
Wells Fargo | Reiterated | Overweight | 2026-04-14 |
Guggenheim | Reiterated | Buy | 2026-04-14 |
Goldman Sachs | Reiterated | Neutral | 2026-04-14 |
Citigroup | Reiterated | Buy | 2026-02-19 |
JP Morgan | Reiterated | Overweight | 2025-10-23 |
BTIG | Reiterated | Buy | 2025-10-21 |
Stephens & Co. | Reiterated | Overweight | 2025-09-09 |
Cantor Fitzgerald | Reiterated | Overweight | 2025-09-09 |
JMP Securities | Reiterated | Market Outperform | 2025-09-08 |
Leerink Partners | Downgraded | Outperform → Market Perform | 2024-11-05 |
Oppenheimer | Reiterated | Outperform | 2024-10-29 |
Stifel | Reiterated | Buy | 2024-09-10 |
Berenberg | Reiterated | Buy | 2023-03-23 |
Capital One | Reiterated | Overweight | 2022-12-28 |
Baird | Reiterated | Outperform | 2022-11-18 |
HC Wainwright & Co. | Reiterated | Buy | 2021-08-11 |
Roth Capital | Reiterated | Buy | 2021-04-19 |
Northland Capital Markets | Reiterated | Outperform | 2020-09-01 |
H.C. Wainwright | Reiterated | Buy | 2020-04-06 |
Citi | Reiterated | Buy | 2019-06-17 |
Jefferies | Reiterated | Buy | 2019-06-17 |
One row per institution, most recent rating